STERIS plc (NYSE:STE – Get Free Report) announced a quarterly dividend on Wednesday, October 28th. Investors of record on Tuesday, November 17th will be paid a dividend of $0.69 per share by the medical equipment provider on Thursday, December 17th. This represents a $2.76 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Tuesday, November 17th.
STERIS has increased its dividend by an average of 0.1% annually over the last three years and has increased its dividend annually for the last 20 consecutive years. STERIS has a dividend payout ratio of 25.1% meaning its dividend is sufficiently covered by earnings. Equities analysts expect STERIS to earn $12.40 per share next year, which means the company should continue to be able to cover its $2.76 annual dividend with an expected future payout ratio of 22.3%.
STERIS Price Performance
Shares of STE stock opened at $232.30 on Friday. The company has a market cap of $22.65 billion, a P/E ratio of 21.96 and a beta of 0.92. The stock’s 50-day moving average is $219.98 and its 200 day moving average is $225.37. STERIS has a 1-year low of $195.14 and a 1-year high of $269.44. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.91 and a quick ratio of 1.35.
STERIS (NYSE:STE – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The medical equipment provider reported $2.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.49 by $0.10. The firm had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.49 billion. STERIS had a net margin of 13.34% and a return on equity of 14.34%. The company’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.34 EPS. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. Research analysts predict that STERIS will post 11.17 earnings per share for the current fiscal year.
Insider Buying and Selling at STERIS
In related news, Director Mohsen Sohi sold 4,058 shares of the company’s stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total value of $956,795.24. Following the sale, the director owned 24,305 shares in the company, valued at $5,730,632.90. This represents a 14.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.12% of the company’s stock.
Institutional Trading of STERIS
Institutional investors and hedge funds have recently bought and sold shares of the business. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of STERIS during the 3rd quarter valued at about $5,559,000. ProShare Advisors LLC raised its holdings in STERIS by 0.5% in the 3rd quarter. ProShare Advisors LLC now owns 20,637 shares of the medical equipment provider’s stock valued at $4,334,000 after buying an additional 102 shares during the period. Vise Technologies Inc. raised its holdings in STERIS by 115.7% in the 3rd quarter. Vise Technologies Inc. now owns 3,520 shares of the medical equipment provider’s stock valued at $739,000 after buying an additional 1,888 shares during the period. Parcion Private Wealth LLC acquired a new position in STERIS in the third quarter valued at about $208,000. Finally, North Dakota State Investment Board lifted its position in STERIS by 2.7% in the third quarter. North Dakota State Investment Board now owns 2,998 shares of the medical equipment provider’s stock valued at $630,000 after buying an additional 78 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.
About STERIS
STERIS plc (NYSE: STE) provides products and services designed to support infection prevention, procedural care and the safe manufacture of healthcare and life sciences products. Its offerings include surgical equipment and operating-room solutions, sterilization and decontamination systems, endoscopy products, cleaning and disinfection technologies, and related consumable products.
The company also provides outsourced sterilization and laboratory services through its Applied Sterilization Technologies business.
Further Reading
- Five stocks we like better than STERIS
- 5 Stocks to Buy in November: Bargains Worth Giving Thanks For
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.
